companydata.dkcompanydata.dk

STRAGEN NORDIC A/S: Financial statements 2022

CVR: 26717825

Source: annual report 2022, Danish Business Authority

01/01/2022 – 31/12/2022

STRAGEN NORDIC A/S (CVR 26717825) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 17,270,850 and a net result of DKK -3,257,245 compared with DKK 254,656 the year before. That is an increase of 298.7% compared with the year before. Equity in the 2022 report amounted to DKK 6,709,469. The solvency ratio was 21.3%.

Gross Profit
DKK 17,270,850
Profit/Loss
DKK -3,257,245
Equity
DKK 6,709,469
Total Assets
DKK 31,542,514
Employees
0

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2022-17.3M-3.3M6.7M0
2021-4.3M255K10M6
2020-6.8M2.6M9.7M6
2019-7M1.7M7.1M6
2018-5.5M1.9M5.4M-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on STRAGEN NORDIC A/S

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2022

Anne Franch Nyquist-Hansen joins the board of STRAGEN NORDIC A/SDec 21, 2022

As of December 21, 2022, Anne Franch Nyquist-Hansen has joined the board of directors of STRAGEN NORDIC A/S.

Antoine Tétard leaves the board of STRAGEN NORDIC A/SDec 21, 2022

As of December 21, 2022, Antoine Tétard has left the board of directors of STRAGEN NORDIC A/S.

Anne Franch Nyquist-Hansen joins STRAGEN NORDIC A/S as adm. dir.Dec 21, 2022

As of December 21, 2022, Anne Franch Nyquist-Hansen is registered as adm. dir. of STRAGEN NORDIC A/S.

Nicholas Stopford joins STRAGEN NORDIC A/S as suppleantDec 21, 2022

As of December 21, 2022, Nicholas Stopford is registered as suppleant of STRAGEN NORDIC A/S.

Antoine Tétard steps down as adm. dir. of STRAGEN NORDIC A/SDec 21, 2022

As of December 21, 2022, Antoine Tétard has stepped down as adm. dir. of STRAGEN NORDIC A/S.

Anne Franch Nyquist-Hansen steps down as suppleant of STRAGEN NORDIC A/SDec 20, 2022

As of December 20, 2022, Anne Franch Nyquist-Hansen has stepped down as suppleant of STRAGEN NORDIC A/S.

Nicholas Stopford joins the board of STRAGEN NORDIC A/SOct 25, 2022

As of October 25, 2022, Nicholas Stopford has joined the board of directors of STRAGEN NORDIC A/S.

Michele Mencarelli leaves the board of STRAGEN NORDIC A/SOct 25, 2022

As of October 25, 2022, Michele Mencarelli has left the board of directors of STRAGEN NORDIC A/S.

Frank Bouisset joins the board of STRAGEN NORDIC A/SJul 1, 2022

As of July 1, 2022, Frank Bouisset has joined the board of directors of STRAGEN NORDIC A/S.

Amine Achite-Henni leaves the board of STRAGEN NORDIC A/SJul 1, 2022

As of July 1, 2022, Amine Achite-Henni has left the board of directors of STRAGEN NORDIC A/S.

About STRAGEN NORDIC A/S

STRAGEN NORDIC A/S is a Danish company of the type Aktieselskab based in Slangerup, founded in 2002. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Anne Franch Nyquist-Hansen and Didier Remi Dargent. The board consists of Didier Remi Dargent (chair), Jean-Yves Paul Etienne Desmottes and Ludovic Alonzi. The company is owned by Strategic Generics France. The company has 4 employees (2026). In 2025, the company reported a gross profit of DKK 4,246,350 and a net result of DKK 529,103 compared with DKK 2,665,035 the year before. Equity in the 2025 report amounted to DKK 9,440,623.

Source: annual report 2025, Danish Business Authority